Patents by Inventor Allen E. Page

Allen E. Page has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12180547
    Abstract: The present disclosure relates to methods of detecting gene expression in a biological sample from an animal. More specifically, this disclosure relates to methods of detecting risk for a catastrophic injury in an animal, such as a non-human athletic animal, based on the expression of select genes within a biological sample from the animal, which can be determined using mRNA expression analysis.
    Type: Grant
    Filed: March 11, 2021
    Date of Patent: December 31, 2024
    Assignee: University of Kentucky Research Foundation
    Inventors: Allen E. Page, David W. Horohov
  • Publication number: 20210285048
    Abstract: The present disclosure relates to methods of detecting gene expression in a biological sample from an animal. More specifically, this disclosure relates to methods of detecting risk for a catastrophic injury in an animal, such as a non-human athletic animal, based on the expression of select genes within a biological sample from the animal, which can be determined using mRNA expression analysis.
    Type: Application
    Filed: March 11, 2021
    Publication date: September 16, 2021
    Inventors: Allen E. Page, David W. Horohov
  • Patent number: 9121856
    Abstract: A method, system, and kit are provided for diagnosing L. intracellularis infection or exposure in a subject. The method includes purifying whole L. intracellularis from host cells and host debris produced in or on a suitable medium and adhering the purified whole L. intracellularis on a suitable material to form an antigen substrate for determining whether a subject produces L. intracellularis-specific antibodies against the antigen to thereby indicate L. intracellularis exposure or infection in the subject. The kit includes purified whole L. intracellularis produced from host cells and host debris adhered to a suitable material to form an antigen substrate adapted for screening serum from a subject. A method for diagnosing L. intracellularis exposure or infection in a subject includes acquiring a serum sample from a subject, introducing the serum sample to an antigen substrate followed by detecting a presence of L. intracellularis-specific antibodies in the serum.
    Type: Grant
    Filed: November 14, 2012
    Date of Patent: September 1, 2015
    Assignee: University of Kentucky Research Foundation
    Inventors: Harold F. Stills, Jr., David W. Horohov, Allen E. Page